Organon & Co. (NYSE: OGN) has a higher price-to-earnings ratio of 4.71x compared to its average ratio. OGN has 36-month beta value of 0.79. Analysts have mixed views on the stock, with 4 analysts rating it as a “buy,” 0 as “overweight,” 5 as “hold,” and 1 as “sell.”
The public float for OGN is 256.91M, and currently, short sellers hold a 3.80% ratio of that float. The average trading volume of OGN on October 15, 2024 was 1.85M shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
OGN) stock’s latest price update
Organon & Co. (NYSE: OGN)’s stock price has soared by 1.15 in relation to previous closing price of 18.10. Nevertheless, the company has seen a gain of 1.15% in its stock price over the last five trading days. https://www.zacks.com/stock/news/2350283/here-s-why-organon-ogn-gained-but-lagged-the-market-today?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|yseop_template_6v2-2350283 reported 2024-10-14 that In the closing of the recent trading day, Organon (OGN) stood at $18.10, denoting a +0.56% change from the preceding trading day.
OGN’s Market Performance
Organon & Co. (OGN) has experienced a 1.15% rise in stock performance for the past week, with a -12.32% drop in the past month, and a -13.48% drop in the past quarter. The volatility ratio for the week is 1.61%, and the volatility levels for the past 30 days are at 2.45% for OGN. The simple moving average for the last 20 days is -2.65% for OGN’s stock, with a simple moving average of -4.65% for the last 200 days.
Analysts’ Opinion of OGN
Many brokerage firms have already submitted their reports for OGN stocks, with JP Morgan repeating the rating for OGN by listing it as a “Underweight.” The predicted price for OGN in the upcoming period, according to JP Morgan is $20 based on the research report published on September 06, 2024 of the current year 2024.
Goldman, on the other hand, stated in their research note that they expect to see OGN reach a price target of $16, previously predicting the price at $33. The rating they have provided for OGN stocks is “Neutral” according to the report published on November 03rd, 2023.
Barclays gave a rating of “Overweight” to OGN, setting the target price at $28 in the report published on September 21st of the previous year.
OGN Trading at -8.57% from the 50-Day Moving Average
After a stumble in the market that brought OGN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -20.74% of loss for the given period.
Volatility was left at 2.45%, however, over the last 30 days, the volatility rate increased by 1.61%, as shares sank -11.24% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -9.66% lower at present.
During the last 5 trading sessions, OGN rose by +0.77%, which changed the moving average for the period of 200-days by +25.97% in comparison to the 20-day moving average, which settled at $18.80. In addition, Organon & Co. saw 26.96% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at OGN starting from Weaver Kirke, who purchase 2,720 shares at the price of $18.36 back on Feb 22 ’24. After this action, Weaver Kirke now owns 15,181 shares of Organon & Co., valued at $49,939 using the latest closing price.
Stock Fundamentals for OGN
Current profitability levels for the company are sitting at:
- 0.18 for the present operating margin
- 0.59 for the gross margin
The net margin for Organon & Co. stands at 0.16. The total capital return value is set at 0.12.
Based on Organon & Co. (OGN), the company’s capital structure generated 0.98 points at debt to capital in total, while cash flow to debt ratio is standing at 0.12. The debt to equity ratio resting at 60.11. The interest coverage ratio of the stock is 2.12.
Currently, EBITDA for the company is 1.55 billion with net debt to EBITDA at 5.2. When we switch over and look at the enterprise to sales, we see a ratio of 2.0. The receivables turnover for the company is 3.84for trailing twelve months and the total asset turnover is 0.52. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.64.
Conclusion
To put it simply, Organon & Co. (OGN) has had a mixed performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
